LT2767285T - Tabletė, apimanti 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoksi]-1h-chinolin-2-oną arba jo druską - Google Patents
Tabletė, apimanti 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoksi]-1h-chinolin-2-oną arba jo druskąInfo
- Publication number
- LT2767285T LT2767285T LTEP12840025.6T LT12840025T LT2767285T LT 2767285 T LT2767285 T LT 2767285T LT 12840025 T LT12840025 T LT 12840025T LT 2767285 T LT2767285 T LT 2767285T
- Authority
- LT
- Lithuania
- Prior art keywords
- butox
- quinolin
- thiophen
- piperazin
- benzo
- Prior art date
Links
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Basic Packing Technique (AREA)
- Supply Of Fluid Materials To The Packaging Location (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011227057 | 2011-10-14 | ||
| PCT/JP2012/076415 WO2013054872A1 (ja) | 2011-10-14 | 2012-10-12 | ７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2767285T true LT2767285T (lt) | 2020-02-10 |
Family
ID=48081918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP12840025.6T LT2767285T (lt) | 2011-10-14 | 2012-10-12 | Tabletė, apimanti 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoksi]-1h-chinolin-2-oną arba jo druską |
Country Status (34)
| Country | Link |
|---|---|
| US (8) | US20140234417A1 (lt) |
| EP (1) | EP2767285B2 (lt) |
| JP (2) | JP6084161B2 (lt) |
| KR (1) | KR102072371B1 (lt) |
| CN (2) | CN103889425B (lt) |
| AP (1) | AP2014007564A0 (lt) |
| AR (1) | AR088319A1 (lt) |
| AU (1) | AU2012321723C1 (lt) |
| BR (1) | BR112014008603A2 (lt) |
| CA (1) | CA2851588C (lt) |
| CL (1) | CL2014000909A1 (lt) |
| CO (1) | CO6950480A2 (lt) |
| CY (1) | CY1122460T1 (lt) |
| DK (1) | DK2767285T4 (lt) |
| EA (1) | EA032930B1 (lt) |
| ES (1) | ES2762479T5 (lt) |
| FI (1) | FI2767285T4 (lt) |
| HR (1) | HRP20200037T4 (lt) |
| HU (1) | HUE047493T2 (lt) |
| IL (1) | IL231513B (lt) |
| IN (1) | IN2014DN02055A (lt) |
| JO (1) | JO3753B1 (lt) |
| LT (1) | LT2767285T (lt) |
| MX (1) | MX376092B (lt) |
| MY (1) | MY173370A (lt) |
| PH (1) | PH12014500607A1 (lt) |
| PL (1) | PL2767285T5 (lt) |
| PT (1) | PT2767285T (lt) |
| SG (2) | SG10201608412SA (lt) |
| SI (1) | SI2767285T2 (lt) |
| TW (1) | TWI634908B (lt) |
| UA (1) | UA114411C2 (lt) |
| WO (1) | WO2013054872A1 (lt) |
| ZA (1) | ZA201402333B (lt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JO3753B1 (ar) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| JP5936732B1 (ja) * | 2015-03-05 | 2016-06-22 | 日本カラコン合同会社 | フィルムコーティング組成物 |
| CN105106142B (zh) * | 2015-09-22 | 2018-05-22 | 成都欣捷高新技术开发有限公司 | 一种含有依匹哌唑的冻干口服制剂及其制备方法 |
| CN106994119A (zh) * | 2016-01-22 | 2017-08-01 | 浙江华海药业股份有限公司 | 含有依匹哌唑或其盐的口腔崩解片及其制备方法 |
| BR112018015369A2 (pt) * | 2016-02-19 | 2018-12-18 | Jiangsu Hengrui Medicine Co., Ltd. | composição farmacêutica contendo inibidor de jak cinase ou sal farmaceuticamente aceitável do mesmo |
| WO2018003762A1 (ja) * | 2016-06-28 | 2018-01-04 | 株式会社日本抗菌総合研究所 | 賦形剤及び錠剤 |
| JP7060878B2 (ja) * | 2016-07-27 | 2022-04-27 | 日本臓器製薬株式会社 | メトトレキサート含有フィルムコーティング錠 |
| WO2018033481A1 (en) | 2016-08-16 | 2018-02-22 | H E X A L Aktiengesellschaft | Immediate release tablet of a benzothiophene compound |
| US20200093821A1 (en) | 2016-08-16 | 2020-03-26 | Hexal Ag | Pharmaceutical Compositions of a Benzothiophene Compound |
| CN106496206A (zh) * | 2016-08-31 | 2017-03-15 | 安徽省润生医药股份有限公司 | 一种依匹哌唑新的制备方法 |
| EP3585392A1 (en) * | 2017-02-23 | 2020-01-01 | Boehringer Ingelheim International GmbH | New medical use of compound iii |
| JP7166754B2 (ja) | 2017-11-22 | 2022-11-08 | 沢井製薬株式会社 | ダサチニブ無水物含有製剤 |
| EP3501506B1 (en) | 2017-12-19 | 2019-10-09 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising brexpiprazole |
| EP3545950A1 (en) | 2018-03-26 | 2019-10-02 | Adamed sp. z o.o. | Pharmaceutical composition comprising brexpiprazole |
| JPWO2021029020A1 (lt) * | 2019-08-13 | 2021-02-18 | ||
| WO2021095092A1 (ja) * | 2019-11-11 | 2021-05-20 | 大塚製薬株式会社 | 口腔内崩壊錠 |
| CN112168794A (zh) * | 2020-10-27 | 2021-01-05 | 浙江诺得药业有限公司 | 一种布瑞哌唑片的制备方法 |
| WO2022218358A1 (zh) * | 2021-04-13 | 2022-10-20 | 上海博志研新药物技术有限公司 | 一种布瑞哌唑物口腔薄膜剂、其制备方法及应用 |
| EP4374856A1 (en) | 2022-11-23 | 2024-05-29 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A process for tablets comprising brexpiprazole |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562375B1 (en) * | 1999-08-04 | 2003-05-13 | Yamanouchi Pharmaceuticals, Co., Ltd. | Stable pharmaceutical composition for oral use |
| US20030153617A1 (en) * | 2001-12-18 | 2003-08-14 | Dalen Frans Van | Simvastatin dosage forms |
| MXPA04010921A (es) * | 2002-05-03 | 2005-05-27 | Israel Inst Biolog Res | Metodos y composiciones para el tratamietno de trastornos del sistema nervioso central y periferico y compuestos novedosos utiles para los mismos. |
| EP1620437B1 (en) | 2003-04-29 | 2009-06-17 | Pfizer Limited | 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension |
| WO2006001787A1 (en) * | 2003-06-09 | 2006-01-05 | Dow Global Technologies Inc. | Stabilized organoborane polymerization initiators and polymerizable compositions |
| JP2006061067A (ja) * | 2004-08-26 | 2006-03-09 | Asahi Kasei Life & Living Corp | 酸素インジケーター |
| GB0504203D0 (en) * | 2005-03-01 | 2005-04-06 | Novartis Ag | Organic compounds |
| ES2526415T3 (es) | 2005-03-17 | 2015-01-12 | Synthon B.V. | Comprimidos farmacéuticos de aripiprazol cristalino de tipo II |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP4315393B2 (ja) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| DE602006004694D1 (de) | 2006-01-05 | 2009-02-26 | Teva Pharma | Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen |
| JP4806595B2 (ja) * | 2006-07-05 | 2011-11-02 | 富士フイルム株式会社 | 固体撮像素子駆動装置及びデジタルカメラ |
| JP4540700B2 (ja) * | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | 医薬 |
| EP2132173B1 (en) * | 2007-02-26 | 2015-10-07 | Merck Sharp & Dohme Corp. | Formulations for cathepsin k inhibitors |
| AR065698A1 (es) * | 2007-03-13 | 2009-06-24 | Takeda Pharmaceutical | Preparacion solida |
| WO2008140051A1 (ja) * | 2007-05-11 | 2008-11-20 | Santen Pharmaceutical Co., Ltd. | 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤 |
| NZ585310A (en) | 2007-10-12 | 2012-02-24 | Astrazeneca Ab | Composition 064 |
| JP5463564B2 (ja) * | 2009-05-22 | 2014-04-09 | 国立大学法人信州大学 | 耐熱性及び耐塩性セルラーゼ製剤 |
| TR201000948A1 (tr) | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazol formülasyonları. |
| AR085840A1 (es) | 2011-04-05 | 2013-10-30 | Otsuka Pharma Co Ltd | Medicamento que contiene un compuesto que es 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi]-1h-quinolin-2-ona |
| DK2694101T3 (en) | 2011-04-06 | 2017-01-09 | Biovaxim Ltd | Pharmaceutical compositions for the prevention and / or treatment of HIV disease in humans |
| JO3753B1 (ar) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
-
2012
- 2012-10-04 JO JOP/2012/0301A patent/JO3753B1/ar active
- 2012-10-09 TW TW101137267A patent/TWI634908B/zh active
- 2012-10-12 PT PT128400256T patent/PT2767285T/pt unknown
- 2012-10-12 LT LTEP12840025.6T patent/LT2767285T/lt unknown
- 2012-10-12 JP JP2013538582A patent/JP6084161B2/ja active Active
- 2012-10-12 HU HUE12840025A patent/HUE047493T2/hu unknown
- 2012-10-12 ES ES12840025T patent/ES2762479T5/es active Active
- 2012-10-12 CN CN201280050586.1A patent/CN103889425B/zh active Active
- 2012-10-12 HR HRP20200037TT patent/HRP20200037T4/hr unknown
- 2012-10-12 AP AP2014007564A patent/AP2014007564A0/xx unknown
- 2012-10-12 EP EP12840025.6A patent/EP2767285B2/en active Active
- 2012-10-12 AR ARP120103801A patent/AR088319A1/es not_active Application Discontinuation
- 2012-10-12 CA CA2851588A patent/CA2851588C/en active Active
- 2012-10-12 SG SG10201608412SA patent/SG10201608412SA/en unknown
- 2012-10-12 PH PH1/2014/500607A patent/PH12014500607A1/en unknown
- 2012-10-12 MX MX2014004135A patent/MX376092B/es active IP Right Grant
- 2012-10-12 PL PL12840025.6T patent/PL2767285T5/pl unknown
- 2012-10-12 US US14/351,325 patent/US20140234417A1/en not_active Abandoned
- 2012-10-12 WO PCT/JP2012/076415 patent/WO2013054872A1/ja not_active Ceased
- 2012-10-12 SG SG2014013783A patent/SG2014013783A/en unknown
- 2012-10-12 BR BR112014008603A patent/BR112014008603A2/pt not_active Application Discontinuation
- 2012-10-12 FI FIEP12840025.6T patent/FI2767285T4/fi active
- 2012-10-12 DK DK12840025.6T patent/DK2767285T4/da active
- 2012-10-12 EA EA201490783A patent/EA032930B1/ru active Protection Beyond IP Right Term
- 2012-10-12 CN CN201710266863.7A patent/CN107397730A/zh active Pending
- 2012-10-12 AU AU2012321723A patent/AU2012321723C1/en active Active
- 2012-10-12 SI SI201231718T patent/SI2767285T2/sl unknown
- 2012-10-12 KR KR1020147010656A patent/KR102072371B1/ko active Active
- 2012-10-12 UA UAA201405029A patent/UA114411C2/uk unknown
- 2012-10-12 MY MYPI2014700632A patent/MY173370A/en unknown
-
2014
- 2014-03-13 IL IL231513A patent/IL231513B/en active IP Right Grant
- 2014-03-19 IN IN2055DEN2014 patent/IN2014DN02055A/en unknown
- 2014-03-28 ZA ZA2014/02333A patent/ZA201402333B/en unknown
- 2014-04-10 CL CL2014000909A patent/CL2014000909A1/es unknown
- 2014-05-07 CO CO14098041A patent/CO6950480A2/es unknown
-
2016
- 2016-02-09 US US15/019,874 patent/US20160158227A1/en not_active Abandoned
-
2017
- 2017-01-20 JP JP2017008854A patent/JP2017088610A/ja active Pending
- 2017-02-27 US US15/444,113 patent/US20170165258A1/en not_active Abandoned
- 2017-09-22 US US15/713,427 patent/US10307419B2/en active Active
-
2019
- 2019-04-12 US US16/383,488 patent/US20190240215A1/en not_active Abandoned
-
2020
- 2020-01-08 CY CY20201100009T patent/CY1122460T1/el unknown
- 2020-10-01 US US17/061,394 patent/US20210023078A1/en not_active Abandoned
-
2022
- 2022-03-07 US US17/653,838 patent/US20220331311A1/en not_active Abandoned
-
2023
- 2023-12-18 US US18/543,053 patent/US20240277703A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2767285T (lt) | Tabletė, apimanti 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoksi]-1h-chinolin-2-oną arba jo druską | |
| HUE056365T2 (hu) | 2-(2,4,5-Helyettesített-anilino)pirimidin származékok | |
| LT3486234T (lt) | Arilu arba heteroarilu pakeisti benzeno junginiai | |
| HUE042322T2 (hu) | Új proteinkináz szabályozó vegyületek | |
| EP2734205A4 (en) | HETEROCYCLIC PROTEIN KINASE HEMMER | |
| LT2694484T (lt) | Pirimidino dariniai, skirti virusinių infekcijų gydymui | |
| CO6950481A2 (es) | Inhibidores de proteínas quinasas | |
| BR112013019509A2 (pt) | derivados heterocíclicos | |
| HUE028396T2 (hu) | Kondenzált heterociklusos vegyületek és alkalmazásuk kártevõk irtására | |
| PT2696848T (pt) | Nanossuspensões de fármaco liofilizadas | |
| IL232035A0 (en) | Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof | |
| FI20175005L (fi) | Radiovälitteisten käyttöteknologioiden (inter-RAT) | |
| BR112013024378A2 (pt) | novos derivados de pirimidina | |
| IL225785A0 (en) | Heterocyclic compounds, compositions comprising the same and uses thereof | |
| BR112014001977A2 (pt) | inibidores seletivos de proteína quinase | |
| BR112014027814A2 (pt) | agentes sinérgicos antimicrobianos. | |
| CL2014003459A1 (es) | Compuestos fungicidas heterocíclicos. | |
| BR112015002078A2 (pt) | inibidores antibacteriais de proteína quinase | |
| BR112013010643A2 (pt) | compostos heterocíclicos | |
| CO6842018A2 (es) | Heterociclicos microbiocidas | |
| IL231096A0 (en) | 2-converted thiazoles (chroman-6-yloxy) and their use as pharmaceutical preparations | |
| EP2736334A4 (en) | DENIBULIN dihydrochloride | |
| ES2397885B1 (es) | Derivados de colismicina. | |
| PH12014500542A1 (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals | |
| EP2860176A4 (en) | AMINOMETHANOL DERIVATIVE INCLUDED IN A HETEROCYCLIC GROUP AND SALT THEREOF, PROCESS FOR THE SYNTHESIS AND USE THEREOF |